Vanda Pharmaceuticals Inc.
VNDA
$4.36
$0.051.16%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -512.58% | -805.05% | -853.29% | -239.24% | -173.32% |
Total Depreciation and Amortization | 33.91% | 72.90% | 170.17% | 190.93% | 126.94% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -809.38% | -199.26% | -80.46% | -125.00% | -89.71% |
Change in Net Operating Assets | 381.37% | 2.27% | -777.91% | 9.36% | -117.28% |
Cash from Operations | -1,160.40% | -393.95% | -223.09% | -168.10% | -112.59% |
Capital Expenditure | 98.95% | 97.64% | 95.33% | -26,725.19% | -20,264.80% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -27.72% | 141.40% | -114.28% | -62.61% | 25.28% |
Cash from Investing | 206.55% | 120.54% | -44.58% | -160.85% | -183.79% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | -- | -- | -- |
Foreign Exchange rate Adjustments | 5,000.00% | -733.33% | -446.81% | 136.25% | -100.38% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 53.33% | 94.17% | -4,330.43% | -161.81% | -151.31% |